59 related articles for article (PubMed ID: 38439878)
1. Application of the Central Nervous System International Prognostic Index (CNS-IPI) score in daily practice: a retrospective analysis apart from the clinical trial at two centers in Brazil.
Fischer T; Zing NP; Fortier SC; Schmidt J; Silveira TB; Chiattone CS
Hematol Transfus Cell Ther; 2024; 46(2):137-145. PubMed ID: 37085346
[TBL] [Abstract][Full Text] [Related]
2. Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma.
Kansara R
Curr Treat Options Oncol; 2018 Sep; 19(11):52. PubMed ID: 30203318
[TBL] [Abstract][Full Text] [Related]
3. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA; Olszewski AJ
Curr Treat Options Oncol; 2018 Jun; 19(8):38. PubMed ID: 29931605
[TBL] [Abstract][Full Text] [Related]
4. Predicting central nervous system relapse in primary breast diffuse large B-cell lymphoma using the stage-modified IPI score: A retrospective cohort study.
Chen GL; Guo P; Wang J; Yu BH; Hong X; Cao J; Lv F
Heliyon; 2024 Mar; 10(5):e26795. PubMed ID: 38439878
[TBL] [Abstract][Full Text] [Related]
5. Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma.
Ma'koseh M; Tamimi F; Abufara A; Abusalem L; Salama O; Saleh Y; Khader R; Faiyoumi BA; Al-Rwashdeh M; Halahleh K
Cureus; 2021 Aug; 13(8):e16802. PubMed ID: 34513408
[TBL] [Abstract][Full Text] [Related]
6. Clinical Effect of CD25 on the Prognosis of Diffuse Large B Cell Lymphoma with Secondary Central Nervous System Relapse.
Oka S; Ono K; Nohgawa M
Pathol Oncol Res; 2020 Jul; 26(3):1843-1850. PubMed ID: 31768966
[TBL] [Abstract][Full Text] [Related]
7. Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL.
Klanova M; Sehn LH; Bence-Bruckler I; Cavallo F; Jin J; Martelli M; Stewart D; Vitolo U; Zaja F; Zhang Q; Mattiello F; Sellam G; Punnoose EA; Szafer-Glusman E; Bolen CR; Oestergaard MZ; Fingerle-Rowson GR; Nielsen T; Trneny M
Blood; 2019 Feb; 133(9):919-926. PubMed ID: 30617197
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of high‑dose methotrexate for CNS prophylaxis in diffuse large B‑cell lymphoma with an intermediate or high CNS‑International Prognostic Index: A single‑center retrospective cohort study.
Al-Mansour M; Absi A; Al-Μufti R; Alahmadi M; El-Ηemaidi I; Alamoudi S; Eldadah S; Aga SS; Khan MA; Alsaeed A
Mol Clin Oncol; 2022 Dec; 17(6):159. PubMed ID: 36338604
[TBL] [Abstract][Full Text] [Related]
9. The iR
Ramchandren R; Johnson P; Ghosh N; Ruan J; Ardeshna KM; Johnson R; Verhoef G; Cunningham D; de Vos S; Kassam S; Fayad L; Radford J; Bailly S; Offner F; Morgan D; Munoz J; Ping J; Szafer-Glusman E; Eckert K; Neuenburg JK; Goy A
EClinicalMedicine; 2023 Feb; 56():101779. PubMed ID: 36618900
[TBL] [Abstract][Full Text] [Related]
10. Molecular and clinical diversity in primary central nervous system lymphoma.
Hernández-Verdin I; Kirasic E; Wienand K; Mokhtari K; Eimer S; Loiseau H; Rousseau A; Paillassa J; Ahle G; Lerintiu F; Uro-Coste E; Oberic L; Figarella-Branger D; Chinot O; Gauchotte G; Taillandier L; Marolleau JP; Polivka M; Adam C; Ursu R; Schmitt A; Barillot N; Nichelli L; Lozano-Sánchez F; Ibañez-Juliá MJ; Peyre M; Mathon B; Abada Y; Charlotte F; Davi F; Stewart C; de Reyniès A; Choquet S; Soussain C; Houillier C; Chapuy B; Hoang-Xuan K; Alentorn A
Ann Oncol; 2023 Feb; 34(2):186-199. PubMed ID: 36402300
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large B-Cell Lymphoma.
Chen GL; Li D; Cao S; Jiang S; Zhang Q; Jin J; Xia Z; Liu Y; Liu X; Zhu Y; Chen Y; Gu L; Hong X; Cao J; Tao R; Lv F
Mediterr J Hematol Infect Dis; 2022; 14(1):e2022066. PubMed ID: 36119461
[TBL] [Abstract][Full Text] [Related]
12. MYD88
Chen R; Zhou D; Wang L; Zhu L; Ye X
Ther Adv Hematol; 2022; 13():20406207211072839. PubMed ID: 35126963
[TBL] [Abstract][Full Text] [Related]
13. Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.
Wilson WH; Wright GW; Huang DW; Hodkinson B; Balasubramanian S; Fan Y; Vermeulen J; Shreeve M; Staudt LM
Cancer Cell; 2021 Dec; 39(12):1643-1653.e3. PubMed ID: 34739844
[TBL] [Abstract][Full Text] [Related]
14. Three-Tier Prognostic Index in Young Adults With Advanced Gastric Cancer.
Chen GL; Huang Y; Zhang W; Pan X; Feng WJ; Zhao XY; Zhu XD; Li WH; Huang M; Chen ZY; Guo WJ
Front Oncol; 2021; 11():667655. PubMed ID: 34568007
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
